Ethoxycarbonyl Group

Ethoxycarbonyl Group

SCHEMBL28308569

CCOC=O.Cc1cc(F)ccc1Br

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
RAB9A P51151 4/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 4/20 0.33
LMNA P02545 3/20 0.33
PKM P14618 2/20 0.33
MEN1 O00255 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 2/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
THRB P10828 1/20 0.32
S1PR1 P21453 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL28032861 0.79 ALDH1A1 (0.39) ALDH1A1RAB9AKMT2AMAPTPKM
Ethoxycarbonyl Group SCHEMBL27323072 0.78 CYP1A2 (0.43) ALDH1A1KMT2AMAPTLMNAMEN1
SCHEMBL29421562 0.78
SCHEMBL306113 0.78
Ammonia Solution, Strong SCHEMBL28164484 0.76 ALDH1A1 (0.40) ALDH1A1RAB9AKMT2AMAPTPKM
SCHEMBL3138385 0.76 ALDH1A1 (0.40) ALDH1A1RAB9AKMT2AMAPTPKM
Fluoride SCHEMBL27656662 0.76 ALDH1A1 (0.40) ALDH1A1RAB9AKMT2AMAPTPKM
Ethoxycarbonyl Group SCHEMBL27755003 0.74 MAOB (0.42) ALDH1A1MAPTLMNACYP1A2CYP2C9
Cyanide SCHEMBL28824673 0.73 ALDH1A1 (0.37) ALDH1A1RAB9AKMT2AMAPTPKM
Ethoxycarbonyl Group SCHEMBL27852394 0.72 HTR2A (0.40) ALDH1A1RAB9AKMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109923114-A Pyrazolopyridine derivatives as HPK1 modulators and their use for the treatment of cancer 因赛特公司 2019-06-21 CN disclosed